Activity Dependence of Endocannabinoid Signaling

内源性大麻素信号传导的活性依赖性

基本信息

  • 批准号:
    7674980
  • 负责人:
  • 金额:
    $ 3.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-03-01 至 2011-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Endocannabinoids (eCBs) are important retrograde signaling molecules that regulate synaptic strength in many brain areas. They are released by postsynaptic cells and activate presynaptic G protein-coupled type- 1 cannabinoid receptors (CBIRs). CB1R signaling can induce both short-term and long-term depression (STD and LTD). CBIRs are the primary target of psychoactive constituents found in marijuana and have also been implicated in brain reward mechanisms. Previous studies have elucidated two cellular mechanisms that control eCB release: elevation of postsynaptic calcium and activation of postsynaptic phospholipase C-beta (PLCP). We will investigate how calcium and PLC(3 interact to control the activity dependence of eCB signaling at synapses onto cerebellar stellate cells (SCs) in acute brain slices. Interactions between calcium and PLCP are difficult to study without the ability to simultaneously measure postsynaptic calcium and synaptic strength. We will dissect contributions of postsynaptic calcium and PLCP to eCB signaling using electrophysiology, 2-photon calcium imaging and pharmacology. This will allow us to address two important issues regarding the activity dependence of eCB signaling. First, we will examine conditions that permit physiologically relevant patterns of spiking to evoke eCB signaling that induces STD or LTD. Second we will examine eCB signaling in response to brief, high frequency and prolonged, low frequency patterns of synaptic activation. Here, we will determine the contributions of postsynaptic calcium and PLCP to eCB signaling and assay for STD and LTD. Finally, we will investigate the role of eCB signaling in associating presynaptic and postsynaptic patterns of activity. Results from these studies will provide insight into the learning rules for STD and LTD. Understanding eCB signaling in SCs has specific importance for cerebellar function and also general importance for eCB signaling elsewhere in the brain. The endocannabinoid system is an intensely studied therapeutic target, because it is involved in brain areas that control learning, memory, motor coordination, appetite, cognition, pain and addiction. Recently, the first drug targeting brain cannabinoid receptors was introduced as an anti-obesity and smoking cessation treatment. Thus, understanding mechanisms that underlie the richness of endocannabinoid signaling provides promise for the development of novel drugs and therapies.
描述(申请人提供):内源性大麻素(ECB)是重要的逆行信号分子,调节许多大脑区域的突触强度。它们由突触后细胞释放,激活突触前G蛋白偶联的1型大麻受体(CBIR)。CB1R信号可以诱导短期和长期的抑郁(STD和LTD)。CBIR是在大麻中发现的精神活性成分的主要靶点,也与大脑奖励机制有关。以往的研究阐明了控制ECB释放的两种细胞机制:突触后钙升高和突触后磷脂酶C-β(Plcp)的激活。我们将研究钙和PLC(3)如何相互作用来控制ECB信号在突触对小脑星状细胞(SCs)的活性依赖性。如果没有同时测量突触后钙和突触强度的能力,就很难研究钙和PLCP之间的相互作用。我们将使用电生理学、双光子钙成像和药理学来剖析突触后钙和PLCP在ECB信号中的作用。这将使我们能够解决有关欧洲央行信号活动依赖的两个重要问题。首先,我们将研究允许生理上相关的尖峰模式来激发ECB信号从而诱导STD或LTD的条件。其次,我们将研究ECB信号对短暂、高频和长时间、低频率突触激活模式的反应。在这里,我们将确定突触后钙和PLCP在ECB信号和STD和LTD检测中的作用。最后,我们将研究ECB信号在联系突触前和突触后活动模式中的作用。这些研究的结果将为STD和LTD的学习规则提供洞察力。了解干细胞中的ECB信号对小脑功能具有特殊的重要性,对大脑其他部位的ECB信号也具有普遍重要性。内源性大麻素系统是一个被广泛研究的治疗靶点,因为它涉及大脑中控制学习、记忆、运动协调、食欲、认知、疼痛和成瘾的区域。最近,第一个靶向大脑大麻素受体的药物被引入作为抗肥胖和戒烟治疗。因此,了解丰富的内源性大麻素信号的机制为开发新的药物和疗法提供了希望。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL MYOGA其他文献

MICHAEL MYOGA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL MYOGA', 18)}}的其他基金

Activity Dependence of Endocannabinoid Signaling
内源性大麻素信号传导的活性依赖性
  • 批准号:
    8033212
  • 财政年份:
    2009
  • 资助金额:
    $ 3.21万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.21万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 3.21万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.21万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.21万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.21万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.21万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.21万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 3.21万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 3.21万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 3.21万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了